Search
for🛒 Where to find Follicusan
Tracking 1 topical product by companies like Minoxidil Express. View product »Learn
5 / 8 resultslearn HMI-115
much-hyped research compound targeting prolactin receptor in scalp
learn GHK-Cu
a copper peptide showing promise in both regrowth and reversing gray hair
learn Caffeine
the stimulant you know and love can be used topically to stimulate hair
learn Minoxidil
An essential vasodilator with some anti-androgenic effects, has excellent safety record
Research
5 / 1000+ results![cAMP Response Element-Binding Protein 1 (CREB) Is a β-Catenin-Regulated Transcription Factor in Squamous Cell Carcinoma (SCC) Cells](/images/research/79680da8-dadf-4fae-8b9e-f682b9d7baea/small/13559.jpg)
research cAMP Response Element-Binding Protein 1 (CREB) Is a β-Catenin-Regulated Transcription Factor in Squamous Cell Carcinoma (SCC) Cells
CREB, a protein that can promote cancer traits, is controlled by β-catenin in skin cancer cells.
![Mutational Landscape of Extramammary Paget Disease](/images/research/eb3610e3-933b-45c0-800c-c44c54108cd1/small/13659.jpg)
research Mutational Landscape of Extramammary Paget Disease
The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.
![Dutasteride for Men with Androgenic Alopecia Unresponsive to Finasteride](/images/research/a182e171-59cd-4c29-8ea8-7531d1049e1d/small/3881.jpg)
research Dutasteride for Men with Androgenic Alopecia Unresponsive to Finasteride
![Cutaneous Adnexal Cysts Revisited: A Novel Classification Based on Morphological and Molecular Features](/images/research/e53adc76-2863-4bac-a2bf-63725c519a5e/small/22982.jpg)
research Cutaneous Adnexal Cysts Revisited: A Novel Classification Based on Morphological and Molecular Features
The conclusion introduces a new way to classify skin cysts using their shape and genetic markers.
![FGF7-Dependent Inhibition of Human Hair Growth by an Osteopontin-Derived Peptide: A Novel Solution for Hirsutism and Hypertrichosis](/images/research/8a3cd2eb-65cc-411c-9fa8-4bb61790eabc/small/25656.jpg)
research FGF7-Dependent Inhibition of Human Hair Growth by an Osteopontin-Derived Peptide: A Novel Solution for Hirsutism and Hypertrichosis
A new peptide, FOL-005, may help treat excessive hair growth by reducing a hair growth promoter, FGF7.
Community Join
5 / 279 resultscommunity Target Area Hair Count (TAHC) increase comparasion of all future treatments in clinical trial phases
Finasteride, Minoxidil, Bioneer CosmeRNA, Technoderma, Kintor, Hope, Breezula, and Follicum treatments showed increases in hair count, with Technoderma showing the highest increase at 24.3 hairs/cm². Amplifica has not yet published results.
community Follicum releases some data from previous phase 2a trial
Follicum discovered that their drug FOL-005 increased hair count by 12 hairs per cm2 in patients with less than 255 hairs per cm2 and is planning a phase 2b trial. They are currently fundraising for the trial, and the drug may also be effective for women.
community When will Breezula, SM04554, Follica FOL-004, follicum FOL-005 arrive in Canada?
The conversation is about the availability of hair loss treatments Breezula, SM04554, Follica FOL-004, and Follicum FOL-005 in Canada after FDA approval, including potential delays, loopholes for obtaining them, and insurance coverage.
community Coegin Pharma to release Follicopeptide (FOL005) by Q2 2025
Follicopeptide (FOL005) by Coegin Pharma will launch as a cosmetic hair growth treatment by Q2 2025, showing similar efficacy to finasteride. Users discuss the benefits and skepticism of releasing hair loss treatments as cosmetics rather than drugs.
community FOL005 claims it's better than Finasteride and Minoxidil.
FOL-005 claims to be more effective than Minoxidil and Finasteride but lacks anti-DHT properties, leading to potential reduced efficacy over time. Concerns are raised about misleading marketing and the safety of alternative treatments like Pyrilutamide and Clascoterone.